Immunotoxic Response of Oleic Acid Anilide and its Hydrolysis Products in Female MRL ^+/+ Mice

REFERENCES

• Abaitua Borda I., Posasa de la Paz M. Clinical Findings. WHO Regional Publications European Series, No. 42, 1992; 27–38
   Google Scholar
• Abaitua Borda I., Philen R M., Posada de la Paz M., Gomez de la Camara A., Diez Ruiz-Navarro M., Gimenez Ribota O., Alvargonzalez Soldevilla J., Terracini B., Severiano Pena S., Fuentes Leal C., Kilbourne E. M. Toxic oil syndrome mortality, the first 13 years. Int. J. Epidemiol. 1998; 27: 1057–1063, [PUBMED], [INFOTRIEVE], [CSA]
   PubMed Web of Science ®Google Scholar
• Ahmed S. A., Penhale W. H., Talal N. Sex hormones, immune responses, and autoimmune diseases: Mechanisms of sex hormone action. Am. J. Pathol. 1985; 121: 531–551, [CSA]
   PubMed Web of Science ®Google Scholar
• Andrews B. S., Eisengerg R. A., Theofilopolos A. N., Izui J. B., Dixon F. J. Spontaneous murine lupus-like syndromes: Clinical and immunopathological manifestations in several strains. J. Exp. Med. 1978; 148: 198–215, [CSA], [CROSSREF]
   Web of Science ®Google Scholar
• Arnaiz-Villena L., Vicario J. L., Serrano-Rios M., Bellas C., Mampaso F. Glomerular basement-membrane anti-bodies and HLA-DR2 in Spanish rapeseed oil desease. New Engl. J. Med. 1982; 307: 1404–1405, [PUBMED], [INFOTRIEVE], [CSA]
   PubMed Web of Science ®Google Scholar
• Balnca M., Boulton P., Brostoff J. Toxic oil syndrome, clinical and immunological characteristics: A review. Clin. Allergy 1984; 14: 165–168, [CSA]
   PubMedGoogle Scholar
• Bell S. A., Faust H., Schmid A, Merurer M. Autoantibodies to C-reactive protein (CRP) and other acute-phase proteins in systemic autoimmune diseases. Clin. Expt. Immunol. 1998; 113: 327–332, [CSA], [CROSSREF]
   PubMed Web of Science ®Google Scholar
• Bell S. A., Hobbs M. V., Rubin R. L. Isotype-restricted hyperimmunity in a murine model of the toxic oil syndrome. J Immunol. 1992; 148: 3369–3376, [PUBMED], [INFOTRIEVE], [CSA]
   PubMed Web of Science ®Google Scholar
• Bell S. A., Kuntze I., Caputo A., Chatelain R. Strain-dependent in vitro and in vivo effects of oleic acid anilides on splenocytes and T-cells in a murine model of the toxic oil syndrome. Food Chem. Toxicol. 2002; 40: 19–24, [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
   PubMed Web of Science ®Google Scholar
• Blasco R., Ruiz-Gutierrez V. Effect of fatty acid anilides on immune responses of Swiss mice. Clin. Exp. Immunol. 1992; 89: 131–135, [PUBMED], [INFOTRIEVE], [CSA]
   PubMed Web of Science ®Google Scholar
• Gallardo S., Pozo V. D., Cárdaba B., Andrés B D., Martin-Orozco E., Fermandez J. C., Tramon P., Psada M., Abaitua I., Palomin P., Lahoz C. Immunological basis of toxic oil syndrome (TOS). Toxicology 1994; 93: 289–299, [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
   PubMed Web of Science ®Google Scholar
• Goebel C., Kubicka-Muranyi M., Tonn T., Gonazlez J., Gleichmann E. Phagocytes render chemicals immunogenic: Oxidation of gold (1) to the T-cell sensitizing gold (III) metabolite generated by mononuclear phagocytes. Arch. Toxicol. 1995; 69: 450–459, [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
   PubMed Web of Science ®Google Scholar
• Gomez-Reino J. J. Immune system disorders associate with adulterated cooking oil. UNEP, ILO, WHO International Program on Chemical Safety IPCS Commission of the European Communities, A. J. Berlin, M. H. Dean, E. M. Draper, F. Smith, Spreafico. Martin Nijhoff Publishers, DordechtThe Netherlands 1987; 376–389
   Google Scholar
• Grandjean E. C. Introduction. Toxic Oil Syndrome Current Knowledge and Future Perspectives. European Series, No. 42, WHO Regional Publications. 1992; 1–2
   Google Scholar
• Heiskanen K. M., Naarala J., Savolainen K. M. The effects of N-(5-vinyl-1,3-thiazolidin-2-ylidene) phenylamine (5-VTPA) on the changes in free intracellular calcium and the production of reactive oxygen metabolites in human leukocytes. Toxicology 1995; 100: 195–202, [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
   PubMed Web of Science ®Google Scholar
• Heiskanen K. M., Savolainen K. M. Effects of 3-phenylamino-1,2-propanediol and its mono- and dioleylesters on the production of reactive oxygen metabolites in human polymoronuclear leukocytea. Toxicol. Lett. 1997; 91: 39–45, [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
   PubMed Web of Science ®Google Scholar
• Izui S., Kelley V. E., Masuda K., Youshida H., Roths J. B., Murphy E. D. Induction of various autoantibodies by mutant gene lpr in several strains of mice. J. Immunol. 1984; 133: 227–233, [PUBMED], [INFOTRIEVE], [CSA]
   PubMed Web of Science ®Google Scholar
• Kaphalia B. S., Ansari G. A. S. Rapid chromatographic analysis of fatty acid anilides suspected of causing toxic oil syndrome. J. Anal. Toxicol. 1991; 14: 1–5, [CSA]
   Google Scholar
• Khan M. F., Kaphalia B. S., Palafox A., Jerrells T. R., Ansari G. A. S. Toxicity of oleic acid anilide in rats. Arch. Environ. Contam. Toxicol. 1991; 21: 571–577, [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
   PubMed Web of Science ®Google Scholar
• Kilbourne E. M., Bernert Posada de la Paz J. T., Jr., Hill M., Jr R. H., Abaitua Borda I., Kilbourne B. W., Zack M M. Chemical correlates of pathogenicity of oil related to the toxic oil syndrome epidemic in Spain. Am. J. Epidemiol. 1988; 127: 1210–1227, [PUBMED], [INFOTRIEVE], [CSA]
   PubMed Web of Science ®Google Scholar
• Koller L. D., Stang B. V., Hall J. A., Posasa de la P. M., Ruiz Mendez M. V. Immunoglobulin and autoantibody responses in MRL/lpr mice treated with ‘toxic oils’. Toxicology 2002; 178: 119–133, [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
   PubMed Web of Science ®Google Scholar
• Kubicka-Muranyi M., Goebels R., Goebel C., Uetrecht J., Gleichmann E. T-Lymphocytes ignore procaimanide, but respond to its reactive metabolites in peritoneal cells: demonstration by the adoptive transfer popliteal lymph node assay. Toxicol. Appl. Pharmcol 1993; 122: 88–94, [CSA], [CROSSREF]
   PubMed Web of Science ®Google Scholar
• Lahoz C., Rose N. R., Robinson C. J. Immunology. WHO Reg Publ Eur Ser. 1992; 42: 143–152, [PUBMED], [INFOTRIEVE], [CSA]
   PubMedGoogle Scholar
• Lahoz C., Tricas L., Lauzurica P., Gurbindo C., Garcia R. Hyper IgE, eosinophilia and immunological hyperreactivity due to ingestion of adulterated rapeseed oil (toxic oil syndrome). Eur. J. Respir. Dis 1983; 64(Suppl. 126)415–418, [CSA]
   Google Scholar
• Murphy E. D., Roths J. B. Autoimmunity and lymphoproliferation: Induction by mutant gene lpr, and acceleration by a male-associated factor in strain BXSB mice. Genetic Control of Autoimmune Disease, N. R. Rose, P. E. Bigazzi, N. L. Warner. Elsevier/North-Holland, New York 1978; 207
   Google Scholar
• Noreiga A. R. Group TESS: Toxic epidemic syndrome, Spain 1981. Lancet 1982; 2: 697–702, [CSA]
   PubMed Web of Science ®Google Scholar
• Notmant D. D., Kurat N., Tan E. M. Profiles of antinuclear antibodies in progressive systemic sclerosis. Arthritis Rheum. 1975; 23: 617–625, [CSA]
   Google Scholar
• Pereira R. S., Black C. M., Arnaiz-Villena A., Vicario J. L., Gomez-Reino J. J. Collagen antibodies in toxic oil disease. Lancet 1985; 2: 273, [CSA], [CROSSREF]
   PubMedGoogle Scholar
• Pestana A., Munoz E. Anilides and the Spanish toxic oil syndrome (news). Nature 1982; 298: 608, [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
   PubMed Web of Science ®Google Scholar
• Tabuenca J. M. Toxic-allergic shock syndrome caused by ingestion of rapeseed oil denatured with aniline. Lancet 1981; 2: 567–568, [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
   PubMed Web of Science ®Google Scholar
• Vazquez Roncero A., Janer Del Valle C., Maestro Duran R., Graciani Constante E. New aniline derivatives in cooking oils associated with the toxic oil syndrome. Lancet 1983; 2: 1024–1025, [PUBMED], [INFOTRIEVE], [CSA]
   PubMed Web of Science ®Google Scholar
• Vicario J. L., Serrano-Rios M., San Andres F., Arnaiz-Villena A. HLA-DR3, DR4 increase in chronic stage of Spainsh oil disease. Lancet 1982; 1: 276, [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
   PubMed Web of Science ®Google Scholar
• Von Schmiedeberg S., Hanten U., Goebel C., Schuppe H. C., Uetrcht J., Gleichmann E. T-cells ignore the parent drug propylthiouracil but are sensitized to a reactive metabolite generated in vivo. Clin. Immunol. Immunopathol. 1996; 80: 162–170, [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
   PubMedGoogle Scholar
• Weatherill A. R., Stand B. S., O'Hara K., Koller L. D., Hall J. A. Investigating the onset of autoimmunity in A.SW mice following treatment with ‘toxic oils‘. Toxicol. Lett 2003; 236: 205–216, [CSA], [CROSSREF]
   Google Scholar
• World Health Organization Report. World Health Organization Regional Office for Europe. WHO, Copenhagen 1984; 8
   Google Scholar